Free Trial

Vir Biotechnology (VIR) SEC Filings & 10K Form

Vir Biotechnology logo
$4.35 -0.73 (-14.37%)
Closing price 08/7/2025 04:00 PM Eastern
Extended Trading
$4.38 +0.03 (+0.69%)
As of 04:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Vir Biotechnology SEC Filings

DateFilerForm TypeView
08/06/2025
4:31 PM
Vir Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2025
11:27 AM
SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
5:46 PM
Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
3:18 PM
Eisner Mark (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2025
7:11 PM
Eisner Mark (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2025
4:59 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2025
4:04 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2025
5:39 PM
MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
4:55 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2025
7:26 PM
BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:22 PM
MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:26 PM
Napolitano Janet (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:27 PM
Ramasastry Saira (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:28 PM
SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:31 PM
Sigal Charles Elliott (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:17 PM
BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:19 PM
Farid Ramy (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:20 PM
Hatfield Jeffrey S. (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
3:29 PM
Napolitano Janet (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2025
7:23 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2025
12:02 PM
BlackRock, Inc. (Filed by)
Vir Biotechnology (Subject)
Form SCHEDULE 13G/A
04/17/2025
8:27 AM
Vir Biotechnology (Filer)
Form ARS
04/17/2025
7:40 AM
Vir Biotechnology (Filer)
Form DEFA14A
04/17/2025
7:33 AM
Vir Biotechnology (Filer)
Form DEF 14A
04/04/2025
3:23 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
6:50 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
11:39 AM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:01 AM
Vir Biotechnology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2025
3:23 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
2:43 PM
HANLY ANN M. (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:44 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:34 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:36 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:37 PM
Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:39 PM
Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:41 PM
O'Byrne Jason (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
7:56 PM
HANLY ANN M. (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
7:57 PM
Sabatini Brent (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
7:57 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
7:38 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
7:40 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the September 1st funding windo
02/19/2025
6:11 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
6:50 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
5:41 PM
Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
5:49 PM
Sabatini Brent (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
6:51 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
7:03 PM
SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:22 PM
SATO VICKI L (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
6:50 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
12:36 PM
O'Byrne Jason (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:20 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:51 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2024
3:20 PM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
3:26 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
11:29 AM
STATE STREET CORP (Filed by)
Vir Biotechnology (Subject)
Form SC 13G/A
10/02/2024
11:09 AM
Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2024
11:07 AM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2024
3:28 PM
Napolitano Janet (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
7:10 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:29 PM
Napolitano Janet (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VIR) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners